MINERALIZED DRINKING WATER AND METHOD OF MAKING SAME
BACKGROUND OF THE INVENTION
There is significance epidemiological evidence found in the literature indicating that the drinking of certain kinds of naturally occurring mineralized waters have the effect of decreasing mortality due to cardiovascular disease. Examples of the most relevant literature of which we are presently aware attesting 5 to such epidemiological evidence are the following publications:
1 ) "MAGNESIUM AND THE HEART," American Heart Journal, June, 1977, Vol. 93, No. 6, pp. 679, 682, B & J. R. Chipperfield; 0
2) "RELATIONSHIP OF METAL METABOLISM TO VASCULAR DISEASE MORTALITY RATES IN TEXAS," The American Journal of Clinical Nutrition, 31 ; July 1978, pp. 1 188-1 197, E.B. 5 Dawson et al;
3) "WATER HARDNESS AND CARDIOVASCULAR MORTALITY," Annals New York Academy of Sciences, 0077-8923/78/0304-0203, pp. 203 - 219, o Neir and Johansen; 1978;
4) "MINERALS, CORONARY HEART DISEASE AND SUDDEN CORONARY DEATH," Adv. Cardioll, Vol. 25, pp. 9 - 24, H. Karppanen et al.; 5 1978;
5) "DRINKING WATER QUALITY AND SUDDEN
DEATH," Adv. Cardiol. Vol. 25, pp. 25 - 26, 1978 S. Punsar et al.
5 6) "MAGNESIUM IN ATHEROSCLEROTIC
CARDIOVASCULAR DISEASE AND SUDDEN DEATH." Acta Cardiologica, Vol. 36, 1981.
7) "GEOCHEMISTRY, SOILS AND i o CARDIOVASCULAR DISEASE" by R. Masironi,
Division of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland, Experienta, 1987.
is 8) "MAGNESIUM AND CERTAIN OTHER ELEMENTS AND
CARDIOVASCULAR DISEASE" in The Science of Total Environment. Elsevier Science Publishers, Amsterdam, 1985.
9) "WATER HARDNESS AND CARDIOVASCULAR o MORTALITY," Annals of the New York Academy of Sciences, 1978.
10) "MORTALITY AND THE CONCENTRATION OF ELEMENTS IN TAP WATER IN COUNTY
25 BOROUGHS IN ENGLAND AND WALES,"
British Journal of Preventive and Social Medicine,
1977.
1 1 ) "ISCHEMIC HEART DISEASE. WATER
3 o HARNESS AND MYOCARDIAL MAGNESIUM,"
CMA Journal, August, 1975;
12) "A REVIEW OF SOME EPIDEMIOLOGICAL FACTORS IN CORONARY HEART DISEASE," The Journal of Medical Society of New Jersey, December, 1975.
5
13) "SHOULD MAGNESIUM THERAPY BE CONSIDERED FOR THE TREATMENT OF CORONARY HEART DISEASE? II. EPIDEMIOLOGICAL EVIDENCE IN o OUTPATIENTS WITH AND WITHOUT
CORONARY HEART DISEASE" by B. Lasserre, M. Spoerri, V. Moullet, M.P Theubet in Magnesium Research (1994 Jun); 7(2): 145-53. [Switzerland]
s 14) "IS HYPOMAGNESEMIA
ARRHYTHMOGENIC?" by T.A. Millane, D.E. Ward, A.J. Camm in Clinical Cardiology (1992 Feb); 15(2):103-8. [London, England.]
0 15) "MINERALS, CORONARY HEART DISEASE AND SUDDEN
CORONARY DEATH," Advances in Cardiology, Volume 25, Basel, 1978.
16) "RELATIONSHIP OF METAL METABOLISM TO VASCULAR 5 DISEASE MORTALITY RATES IN TEXAS," by E.B. Dawson in
American Journal of Clinical Nutrition, 1978.
17) "NEW CONCEPTS IN THE CARDIOPROTECTIVE ACTION OF MAGNESIUM AND TAURINE DURING THE CALCIUM o PARADOX AND ISCHAEMIA OF THE HEART" by M.S.
Suleiman in Magnesium Research ( 1994 Dec); 7(3-4):295-312. [Bristol, England].
18) "MAGNESIUM ANTAGONIZES THE ACTIONS OF
5 LYSOPHOSPHATIDYL CHOLINE (LPC) IN MYOCARDIAL
CELLS: A POSSIBLE MECHANISM FOR ITS ANTIARRHYTHMIC EFFECTS" by R.C. Prielipp, J.F. Butterworth IV, P.R. Roberts, K.W. Black, G.P. Zaloga in Anesthesiology Analog (1995 Jun); 80(6): 1083-7. 0
19) "PREVENTIVE EFFECTS OF MAGNESIUM ON RAISED SERUM LIPID PEROXIDE LEVELS AND AORTIC CHOLESTEROL DEPOSITION IN MICE FED AN ATHEROGENIC DIET" by Y. 5 Yamaguchi, S. Kitagawa, M. Kunitomo, M. Fijiwara in Magnesium Research (1994 Mar); 7(l ):31-7. [Japan]
20) "COMBINED EFFECTS OF MAGNESIUM o DEFICIENCY AND AN ATHEROGENIC LEVEL
OF LOW DENSITY LIPOPROTEIN ON UPTAKE AND METABOLISM OF LOW DENSITY LIPOPROTEIN BY CULTURED HUMAN ENDOTHELIAL CELLS. II. ELECTRON 5 MICROSCOPIC DATA" by S. Yokoyama, J. Gu, S.
Kashima. H.I. Nishida. T.L. Smith, F.A. Kummerow in Magnesium Research (1994 Jun); 7(2):97-105.
21 ) "EFFECT OF WATER CONTAINING CALCIUM o AND MAGNESIUM SULFATES ON THE
ELIMINATION OF CHOLESTEROL IN THE
RAT" by C. Troussaint, E. Peuchant, C. Courtes, R. Jensen, J. Canellas in Archive of Int. Physiological Biochemistry ( 1988 Jun); 96(2): 89- 100. [Bordeaux, France]
5
22) "SERUM AND ERYTHROCYTE MAGNESIUM CONCENTRATIONS AND MIGRAINE" by J. Thomas, E. Thomas, E. Tomb m Magnesium Research (1992 Jun); 5(2):127-30. 0
23) "PREVENTION OF THE RECURRENCE OF URINARY LITHIASIS: MINERAL WATER WITH HIGH OR LOW CALCIUM CONTENT?" by M. Sommaπva, P. Rigatti, M.R. Viola in Minerva Med s (1987 Dec 31); 78(24): 1823-9. [Published in Italian.
Milan, Italy]
24) "ABSORBABILITY OF THE CALCIUM IN A HIGH-CALCIUM MINERAL WATER" by R.P. 0 Heaney, M.S. Dowell in Osteoporosis International
(1994 Nov); 4(6):323-4.
25) MAGNESIUM AND GLUCOSE METABOLISM" by P.J. Lefebvre. G. Paolisso, A.J. Scheen in 5 Therapie (1994 Jan-Feb); 49(1): 1-7. [Pubhshed in
French. Belgium.]
26) "CHROMIUM NUTRITION IN THE ELDERLY" by R.A. Anderson from Vitamin and Mineral o Nutπtion Laboratory, Beltsville Human Nutrition
Research Center, U.S. Department of Agπculture,
Agricultural Research Service. Beltsville, MD in Handbook of Nutπtion in the Aged. R.R. Watson, Ed; CRC Press, Boca Raton, FL, pp. 385-92, 1994.
27) "SERUM CHROMIUM AND
ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISEASE" by H.A. Newman, R.F. Leighton, R.R. Lanese, N.A. Freeland in Clinical Chemistry ( 1978 April) 24(4):541-4.
28) "CHROMRJM DEFICIENCY AND
CARDIOVASCULAR RISK" by M. Simonoff in Cardiovascular Research (1984 Oct); 19(10):591-6.
29) "CHROMIUM DEPLETION IN THE
PATHOGENESIS OF DIABETES AND ATHEROSCLEROSIS" by E. Boyle Jr., B. Modschein, H.H. Dash in Southern Medical Journal (1977 Dec); 70(12): 1449-53.
30) "CHROMIUM AND CHOLESTEROL-INDUCED ATHEROSCLEROSIS IN RABBITS" by A.S. Abraham, B.A. Brook, U. Eylath in Annals of Nutritional Metabolism ( 1991 )35(4):203-7.
31 ) "RECENT ADVANCES IN THE CLINICAL AND BIOCHEMICAL EFFECTS IN CHROMIUM DEFICIENCY" by R.A. Anderson from Vitamin and Mineral Nutrition Laboratory, Belsville Human Nutrition Research Center. U.S. Department of
Agriculture, Agricultural Research Service,
Beltsville. MD in Essential and Toxic Trace Elements in Human Health and Disease: An Update, pp.221-34, 1993.
The high incidence of hypertension is significantly related to the intake of sodium, and reducing sodium in the diet reduces hypertension. It is therefore advantageous to rid the body of excess sodium.
In U.S. Patent No. 4,325,975 "Mineralized Drinking Water and Method of Making Same," the inventors herein obtained patent coverage on a drinking water including strontium, magnesium, calcium and lithium salts. No mention or suggestion was made to include chromium salts.
However, neither the naturally occurring drinking waters of which we are aware nor any manufactured waters provide a formulation for mineralized drinking water which, in our opinion, is an optimum formulation in terms of maximizing the decrease in both the incidence of cardiovascular disease and the mortality rate due to cardiovascular disease.
BRIEF SUMMARY OF THE INVENTION
The optimal mineralized drinking, i.e., potable water formulation strongly appears to have great utility in preventing cardiovascular diseases and is an aqueous solution consisting essentially of:
10- 100 mcg/liter Chromium ion; 50-100 mg/liter Magnesium ions; 60-125 mg/liter Calcium ions; and 0.06-0.15 mg/liter Lithium ions.
All the chemical elements are present in the ionic form - as water soluble salts, e.g., as sulfates. nitrates, or chlorides of the elements. The mineral water contains no sodium ions.
This precise combination of ingredients, and the concentration thereof, are believed to be most beneficial in preventing various cardiovascular diseases, especially hypertensive heart disease, hypertension, arteπosclerotic and degenerative heart disease, and generalized arteriosclerosis.
Each of the ionic forms of the elements appear to contπbute to the prevention of cardiovascular disease in vaπous ways. The introduction of lithium salts into the mineralized formulation acts as a natural diuretic removing excess or harmful levels of sodium, potassium and water, thereby reducing the incidence of hypertension and other cardiovascular conditions that may be induced by the presence of excessive sodium salts. Lithium also appears to have blood glucose lowering effects in hyperglycemic subjects. Acting in concert with the lithium salts are the water-soluble magnesium salts, which are very important as an activator of many enzymes, such as those concerned with the metabolism of adenosme triphosphate (ATP) and those essential for maintaining healthy myocardial tissues and healthy myocardial functioning. Magnesium salts are found to aid in preventing "sudden death" after myocardial infraction possibly by reducing the incidence and degree of cardiac arrhythmias following infraction, and by protecting against cardiotoxic agents. Calcium and strontium salts, too, have been found to reduce cardiovascular disease, possibly by competing with sodium and potassium for intestinal absorption and by increasing excretion of sodium.
Calcium also has significant hypohpemic effects (reducing fat in the blood).
The literature is voluminous on the advantages of reduced cardiovascular disease fortuitously occurring to those who happen to live in areas of the world which have naturally occurring highly mineralized waters. For example. West
Texas is reputed to have both the hardest, most heavily mineralized drinking water
and the lowest cardiovascular mortality rates m the United States, a country which has the second highest national cardiovascular mortality rate m the world. See "Relationship of Metal Metabolism to Vascular Disease Mortality Rates m Texas," by E B Dawson in Ameπcan Journal of Clinical Nutπtion. 1978 However, of the 5 pπor art references of which the inventors are aware, none attempt to produce a mineralized potable water which has a zero sodium level, together with a combination of metals (in the form of water-soluble salts thereof) having known positive effects in decreasing the incidence and the effects of cardiovascular disease - and making this mineralized water available to the general public 0 regardless of their geographical location.
As noted above, the mineralized water of the invention has no sodium ion (l e table salt) The high incidence of hypertension is significantly related to the intake of sodium, from both food and water 5
The mineralized water of the invention causes less sodium to be absorbed from the gut because its minerals complete with sodium m the intestinal lumen (gut) for absorption Thus, much of the sodium ingested with food is not absorbed from the gut, but is instead excreted with bowel waste mateπal In addition, the o mineralized water bπngs about increased uπnary excretion of sodium by diuretic action and by the minerals competing with the kidneys for re-absorption Accordingly, the kidneys get πd of more sodium
The positive health effects of magnesium and calcium also include (1) 5 loweπng the blood cholesterol levels, particularlv of the low-density hpoprotein
(LDL), the so-called bad form of cholesterol which clogs arteπes, (2) improvements in the state of migraine patients, (3) reducing the incidence of recurπng kidnev stones, and (4) reducing diabetes
o Chromium deficiency in the human body can lead to numerous health problems including
impaired glucose tolerance fasting hyperglycemia [abnormally high blood sugar] elevated circulating insulin elevated blood cholesterol - elevated blood triglycerides decreased HDL cholesterol peripheral neuropathy [damage to peripheral nerves in the body] brain disorders
There is significant evidence that people with coronary artery disease have a lower serum chromium concentration than do those patients with normally patent (open) arteries.
The recommended safe and adequate adult daily intake for chromium is 50 to 200 micrograms. However, those are reliable indications that females and males are consuming roughly 40 and 60 percent of the suggested minimum, respectively.
The potable water of the invention provides an ideal vehicle to carry the essential mineral chromium, magnesium, calcium and lithium, in an ionic form which is easy to consume, and which is easily absorbed into the bloodstream.
DESCRIPTION OF THE PREFERRED EMBODIMENT
The mineralized water of this invention consists essentially of the following ingredients, ranges and proportions, viz an aqueous solution of:
10-100 mcg/liter Chromium ions; 50-100 mg/liter Magnesium ions; 60-125 mg/liter Calcium ions; and 0.06-0.15 mg/liter Lithium ions.
10
The optimal formulation lies at or near the upper limits stated above
The stated metallic ions are added to distilled water in the form of water soluble salts thereof, e g., as the sulphates, nitrates, or chloπdes. No sodium is added.
One presently preferred method of preparation of the mineralized water of this invention utilizes a distilled water base into which the predetermined concentration of e.g., chromium chloπde, magnesium sulphate, calcium chloπde, and lithium chloπde are added. Other forms of salts can also be utilized.
The resulting mineralized water is then packed in suitable containers for later distπbution and use
It is also within the scope of this invention to prepare the potable mineralized water by simply adding a tablet, capsule, pellet or powder containing the water soluble salts of the metals to distilled water m a sufficient amount of produce the aforedescπbed concentration limits of metallic ions in the water, i.e.,
10-100 mcg/liter Chromium ions,
50-100 mg/liter Magnesium ions, 60-125 mg/liter Calcium ions; and 0 06-0.15 mg/liter Lithium ions.
The optimal formulation lies at or near the upper limits stated above
The epidemiological evidence indicates that the optimum formulation of mineralized water for daily ingestion purposes, I e., for use as a dπnking water, should not only contain the metallic ions of the foregoing salts but should be devoid of sodium salts A mineralized water based on this formulation does not appear in nature to the best of our knowledge yet appears to offer to offer
11
maximum protection against the development and effects of cardiovascular disease.
Vaπous modifications of the inventions will be apparent to those skilled in the art. We intend, therefore, to be bound only by the claims which follow.
12